Literature DB >> 6824570

Intra-tumoural variation of oestrogen receptor status in endometrial cancer.

L Castagnetta, M Lo Casto, T Mercadante, L Polito, S Cowan, R E Leake.   

Abstract

Soluble and nuclear oestrogen receptor status was determined in both the central and peripheral portions of tumour for 37 cases of adenocarcinoma of the endometrium. Of these, 29 had functional receptor in the peripheral biopsy, but only 19 retained functional receptor in the centre. Six of the 10 patients whose tumours showed this difference came from the group of 12 patients who were immediately post-menopausal (4.50 +/- 1.45 y post-menopausal age). Receptor status was not related to tumour classification into histological grades I and II. However, receptor-negative central biopsies were significantly more likely (P less than 0.05) to be Grade III. Early relapse was also related to a receptor-negative central biopsy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824570      PMCID: PMC2011289          DOI: 10.1038/bjc.1983.34

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Estradiol binding and metabolism in human endometrial hyperplasia and adenocarcinoma.

Authors:  E Gurpide; S B Gusberg; L Tseng
Journal:  J Steroid Biochem       Date:  1976 Nov-Dec       Impact factor: 4.292

2.  High affinity binding of oestradiol-17 beta in the nuclei of human endometrial cells.

Authors:  W P Soutter; K Hamilton; R E Leake
Journal:  J Steroid Biochem       Date:  1979-05       Impact factor: 4.292

3.  Distribution of the oestrogen-induced protein and of total protein between endometrial and myometrial fractions of the immature and mature rat uterus.

Authors:  B S Katzenellenbogen; R E Leake
Journal:  J Endocrinol       Date:  1974-12       Impact factor: 4.286

4.  Nuclear progestin receptors in normal and malignant human endometrium.

Authors:  P D Feil; W J Mann; R Mortel; C W Bardin
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

5.  Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors.

Authors:  T Thorsen
Journal:  J Steroid Biochem       Date:  1979-06       Impact factor: 4.292

6.  Characterization and comparison of receptors for 17 beta-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma.

Authors:  K Pollow; H Lübbert; E Boquoi; G Kreuzer; B Pollow
Journal:  Endocrinology       Date:  1975-02       Impact factor: 4.736

7.  Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.

Authors:  F Bayard; S Damilano; P Robel; E E Baulieu
Journal:  J Clin Endocrinol Metab       Date:  1978-04       Impact factor: 5.958

8.  Relationship of oestrogen-receptor status to survival in breast cancer.

Authors:  H M Bishop; R W Blamey; C W Elston; J L Haybittle; R I Nicholson; K Griffiths
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

9.  Inter-site variation of oestrogen receptors in human breast cancers.

Authors:  W D Tilley; D D Keightley; E L Cant
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

10.  17 beta-estradiol, 5 alpha-dihydrotestosterone, progesterone and cortisol receptors in normal and neoplastic human endometrium.

Authors:  G Prodi; C De Giovanni; M C Galli; G Gola; S Grilli; R Rocchetta; C Orlandi
Journal:  Tumori       Date:  1979-04-30
View more
  7 in total

1.  Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy.

Authors:  L Castagnetta; G Carruba; M Calabrò; L Polito; L Blasi; M Pavone-Macaluso
Journal:  Urol Res       Date:  1991

2.  Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate.

Authors:  L Castagnetta; G Carruba; E Fecarotta; M Lo Casto; R Cusimano; M Pavone-Macaluso
Journal:  Urol Res       Date:  1992

3.  Determination of oestrogen receptors with monoclonal antibodies in fine needle aspirates of breast carcinoma.

Authors:  A Marrazzo; G La Bara; P Taormina; P Bazan
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

4.  Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer?

Authors:  L Castagnetta; A Traina; A Di Carlo; G Carruba; M Lo Casto; M Mesiti; R Leake
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

5.  The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.

Authors:  L Castagnetta; A Traina; G Carruba; E Fecarotta; G Palazzotto; R Leake
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

6.  Hormonal Receptor Expression in Endometrial Carcinoma: A Retrospective Immunohistochemical Study in a Nigerian Tertiary Hospital.

Authors:  Segun Samson Odetola; Mustapha Akanji Ajani; Oluwadamilare Iyapo; Ayodeji A Salami; Clement Abu Okolo
Journal:  J West Afr Coll Surg       Date:  2022-03-26

7.  Soluble and nuclear oestrogen receptor status of advanced endometrial cancer in relation to subsequent clinical prognosis.

Authors:  L Castagnetta; M Lo Casto; O M Granata; M Calabro; M Ciaccio; R E Leake
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.